Device manufacturer C.R. Bard Inc. said it reached a definitive agreement to acquire Medivance, a Louisville, Colo.-based medical technology company.
The deal has a purchase price of approximately $250 million, according to a news release. Bard also said that Medivance, which markets technology used to treat therapeutic hypothermia, will be integrated into Bard's medical division. Bard is based in Murray Hill, N.J.
